396 related articles for article (PubMed ID: 36757537)
1. The Evolving Landscape of Fecal Microbial Transplantation.
Shao T; Hsu R; Hacein-Bey C; Zhang W; Gao L; Kurth MJ; Zhao H; Shuai Z; Leung PSC
Clin Rev Allergy Immunol; 2023 Oct; 65(2):101-120. PubMed ID: 36757537
[TBL] [Abstract][Full Text] [Related]
2. Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile).
Minkoff NZ; Aslam S; Medina M; Tanner-Smith EE; Zackular JP; Acra S; Nicholson MR; Imdad A
Cochrane Database Syst Rev; 2023 Apr; 4(4):CD013871. PubMed ID: 37096495
[TBL] [Abstract][Full Text] [Related]
3. Changes in microbial ecology after fecal microbiota transplantation for recurrent C. difficile infection affected by underlying inflammatory bowel disease.
Khanna S; Vazquez-Baeza Y; González A; Weiss S; Schmidt B; Muñiz-Pedrogo DA; Rainey JF; Kammer P; Nelson H; Sadowsky M; Khoruts A; Farrugia SL; Knight R; Pardi DS; Kashyap PC
Microbiome; 2017 May; 5(1):55. PubMed ID: 28506317
[TBL] [Abstract][Full Text] [Related]
4. Alteration of gut microbial composition associated with the therapeutic efficacy of fecal microbiota transplantation in Clostridium difficile infection.
Lee PC; Chang TE; Wang YP; Lee KC; Lin YT; Chiou JJ; Huang CW; Yang UC; Li FY; Huang HC; Wu CY; Huang YH; Hou MC
J Formos Med Assoc; 2022 Sep; 121(9):1636-1646. PubMed ID: 34836663
[TBL] [Abstract][Full Text] [Related]
5. Effective fecal microbiota transplantation for recurrent Clostridioides difficile infection in humans is associated with increased signalling in the bile acid-farnesoid X receptor-fibroblast growth factor pathway.
Monaghan T; Mullish BH; Patterson J; Wong GK; Marchesi JR; Xu H; Jilani T; Kao D
Gut Microbes; 2019; 10(2):142-148. PubMed ID: 30183484
[TBL] [Abstract][Full Text] [Related]
6. Application and development of fecal microbiota transplantation in the treatment of gastrointestinal and metabolic diseases: A review.
Mahmoudi H; Hossainpour H
Saudi J Gastroenterol; 2023; 29(1):3-11. PubMed ID: 36412458
[TBL] [Abstract][Full Text] [Related]
7. Fecal Microbiota Transplantation Increases Colonic IL-25 and Dampens Tissue Inflammation in Patients with Recurrent Clostridioides difficile.
Jan N; Hays RA; Oakland DN; Kumar P; Ramakrishnan G; Behm BW; Petri WA; Marie C
mSphere; 2021 Oct; 6(5):e0066921. PubMed ID: 34704776
[TBL] [Abstract][Full Text] [Related]
8. Fecal Microbiota Transplantation and Microbial Therapeutics for the Treatment of Clostridioides difficile Infection in Pediatric Patients.
Bernard R; Hourigan SK; Nicholson MR
J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S58-S63. PubMed ID: 34791396
[TBL] [Abstract][Full Text] [Related]
9. Gram-Negative Taxa and Antimicrobial Susceptibility after Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection.
Steed DB; Wang T; Raheja D; Waldman AD; Babiker A; Dhere T; Kraft CS; Woodworth MH
mSphere; 2020 Oct; 5(5):. PubMed ID: 33055258
[TBL] [Abstract][Full Text] [Related]
10. Fecal microbiota transplantation for treatment of patients with recurrent
Voth E; Khanna S
Expert Rev Anti Infect Ther; 2020 Jul; 18(7):669-676. PubMed ID: 32266848
[TBL] [Abstract][Full Text] [Related]
11. Dissecting mechanisms of fecal microbiota transplantation efficacy in disease.
Andary CM; Al KF; Chmiel JA; Gibbons S; Daisley BA; Parvathy SN; Maleki Vareki S; Bowdish DME; Silverman MS; Burton JP
Trends Mol Med; 2024 Mar; 30(3):209-222. PubMed ID: 38195358
[TBL] [Abstract][Full Text] [Related]
12. Understanding the mechanisms of efficacy of fecal microbiota transplant in treating recurrent
Martinez-Gili L; McDonald JAK; Liu Z; Kao D; Allegretti JR; Monaghan TM; Barker GF; Miguéns Blanco J; Williams HRT; Holmes E; Thursz MR; Marchesi JR; Mullish BH
Gut Microbes; 2020 Nov; 12(1):1810531. PubMed ID: 32893721
[TBL] [Abstract][Full Text] [Related]
13. Fecal microbiota transplantation beyond Clostridioides difficile infections.
Wortelboer K; Nieuwdorp M; Herrema H
EBioMedicine; 2019 Jun; 44():716-729. PubMed ID: 31201141
[TBL] [Abstract][Full Text] [Related]
14. Key determinants of success in fecal microbiota transplantation: From microbiome to clinic.
Porcari S; Benech N; Valles-Colomer M; Segata N; Gasbarrini A; Cammarota G; Sokol H; Ianiro G
Cell Host Microbe; 2023 May; 31(5):712-733. PubMed ID: 37167953
[TBL] [Abstract][Full Text] [Related]
15. Recovery of the gut microbiome following fecal microbiota transplantation.
Seekatz AM; Aas J; Gessert CE; Rubin TA; Saman DM; Bakken JS; Young VB
mBio; 2014 Jun; 5(3):e00893-14. PubMed ID: 24939885
[TBL] [Abstract][Full Text] [Related]
16. Encapsulated Fecal Microbiota Transplantation: Development, Efficacy, and Clinical Application.
Halaweish HF; Boatman S; Staley C
Front Cell Infect Microbiol; 2022; 12():826114. PubMed ID: 35372103
[TBL] [Abstract][Full Text] [Related]
17. Pediatric Fecal Microbiota Transplantation in Recurrent
Parnell JM; Nicholson MR; Kellermayer R; Kahn SA
Pediatr Ann; 2021 Dec; 50(12):e515-e521. PubMed ID: 34889135
[TBL] [Abstract][Full Text] [Related]
18. The Super-Donor Phenomenon in Fecal Microbiota Transplantation.
Wilson BC; Vatanen T; Cutfield WS; O'Sullivan JM
Front Cell Infect Microbiol; 2019; 9():2. PubMed ID: 30719428
[TBL] [Abstract][Full Text] [Related]
19. Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent
Mullish BH; McDonald JAK; Pechlivanis A; Allegretti JR; Kao D; Barker GF; Kapila D; Petrof EO; Joyce SA; Gahan CGM; Glegola-Madejska I; Williams HRT; Holmes E; Clarke TB; Thursz MR; Marchesi JR
Gut; 2019 Oct; 68(10):1791-1800. PubMed ID: 30816855
[TBL] [Abstract][Full Text] [Related]
20. A microbial consortium alters intestinal
Rooney AM; Cochrane K; Fedsin S; Yao S; Anwer S; Dehmiwal S; Hota S; Poutanen S; Allen-Vercoe E; Coburn B;
mBio; 2023 Aug; 14(4):e0348222. PubMed ID: 37404011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
